Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4B
|
pubmed:dateCreated |
1997-10-29
|
pubmed:abstractText |
p53-mutations are of major importance in the development of human malignancies and occur frequently in head and neck cancer. The detection of serum p53-antibodies has been performed for a number of different cancers. For head and neck cancer though, the occurrence of serum p53-antibodies has not been determined so far.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2873-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9329551-Adult,
pubmed-meshheading:9329551-Aged,
pubmed-meshheading:9329551-Antibodies,
pubmed-meshheading:9329551-Carcinoma, Squamous Cell,
pubmed-meshheading:9329551-Head and Neck Neoplasms,
pubmed-meshheading:9329551-Humans,
pubmed-meshheading:9329551-Middle Aged,
pubmed-meshheading:9329551-Tumor Suppressor Protein p53
|
pubmed:articleTitle |
Head and neck cancer and p53-immunogenicity.
|
pubmed:affiliation |
Department of Otorhinolaryngology, Head and Neck Surgery, University of Kiel, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|